The efficacy of nebulized procaterol versus nebulized salbutamol for the treatment of moderate acute asthma: A randomized, double-blind, parallel group study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 49, Issue 10, 2011, Pages 614-621

  Mangunnegoro, H ^a   Novariska, F ^a   Wiyono, W H ^a   Setiawati, A ^a   Louisa, M ^a  

^a UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Moderate acute asthma; Nebulized; Procaterol; Salbutamol

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; PROCATEROL; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEART PALPITATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEBULIZATION; PARALLEL DESIGN; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SINUS TACHYCARDIA;

ACUTE DISEASE; ADOLESCENT; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; ALBUTEROL; ASTHMA; CARBON DIOXIDE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; OXYGEN; PEAK EXPIRATORY FLOW RATE; PROCATEROL;

EID: 80053608042     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201513     Document Type: Article

References (24)

1. Rodrigo GJ, Rodrigo C, Hall JR. Acute asthma in adults: a review. Chest. 2004; 125: 1081-1102. doi:10.1378/chest.125.3.1081 PubMed (Pubitemid 38367305)
2. Baseman ED, Barnes PJ, Bousquet J, Fitzgerald M, Haahtela T, O'Byrne P et al. Clinical diagnosis. In: Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. NHBLI, WHO revised 2008.
3. Li JT, Pearlman DS, Nicklas BA, Lowenthal M, Rosenthal R.R. Algorithm for the diagnosis and management of asthma: a practice parameter update. Ann Allergy Asthma Immunol. 1998; 81: 415-420. PubMed doi:10.1016/S1081-1206(10) 63138-9
4. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, Fitzgerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31: 143-178. doi:10.1183/09031936.00138707 PubMed
5. Yoshizaki S, Tanimura K, Tamada S, Yabuuchi Y, Nakagawa K. Sympathomimetic amines having a carbostyril nucleus. J Med Chem. 1976; 19: 1138-1142. doi:10.1021/jm00231a011 PubMed
6. Petty TL, Brandan ML, Busse WW, Chervinsky P, Schoenweter W, Beaupre A, Boulet LP, Mazza J. A comparison of oral procaterol and albuterol in reversible airflow obstruction. Am Rev Respir Dis. 1988; 138: 1504-1509. PubMed (Pubitemid 19005438)
7. Kishida M, Sasamoto A, Saito S, Aoki T, Iikura Y. Bronchial hyperresponsiveness changes after 5 months of regular procaterol inhalation therapy in asthmatic children. J Asthma. 1993; 30: 37-43. doi:10.3109/ 02770909309066378 PubMed (Pubitemid 23066022)
8. Ferres J, Llacer MA, Solis MJ, Moran E, Salmeron M, Zorrilla AT et al. Comparative study of salbutamol versus procaterol in the treatment of acute bronchospasm in children. Curr Ther Res. 1993; 53: 215-221. doi:10.1016/S0011- 393X(05)80249-8
9. 2 agonists in asthma treatment. New York: Marcell Dekker Inc. 1997. p. 160-161.
10. Tsuda T, Takeshi Y, Takasu A, Itoh S, Takeuchi A, Hayakawa K et al. Clinical effects of procaterol and isoproterenol administered by nebulizer with IPPB on asthmatics. Japanese J Resp. 1986; 6: 688-693. (Pubitemid 17033015)
11. Tsubura E, Miyamoto T, Kasukawa R, Ohara M, Makino S, Toda M et al. Clinical evaluation of procaterol inhalation solution in bronchial asthma at 14 institutions. Curr Ther (Seaforth). 1985; 17: 1991.
12. Pramahdi S, Yunus F, Wiyono WH, Hupudio H. The comparative efficacy study of salbutamol inhalation and salbutamol/ipratropium bromide combination in moderate acute asthma (in Indonesian language). J Respir Indon. 2006; 26: 99-110.
13. Product information of procaterol in Japan.
14. Pneumobile Praject Indonesia Study Graup. Spirometric values of healthy Indonesian. Pneumobile Project Indonesia. Jakarta; 1992.
15. Sari A, Yunus F, Wiyono WH, Jusuf A, Hupudio H. The efficacy of nebulized fluticasone propionate in severe acute asthma compared to intravenous methylprednisolone. Indon Med J. 2005; 55: 463-471.
16. Barasila Z, Yunus F, Wiyono WH, Soerjanto. Comparison of efficacy combination of inhaled formoterol/budesonide turbuhaler vs. combination of nebulized salbutamol/ipratropium bromide on moderate asthma acute exacerbation in Persahabatan Hospital. Med J Indones. 2006; 15: 34-42.
17. Imelda S, Yunus F, Wiyono WH. Correlation between grade of asthma and quality of life assessed by Asthma Quality of Life Questionnaire. Indon Med J. 2007; 54: 435-445.
18. Noseda A, Yernault JC. Sympathomimetics in acute severe asthma: inhaled or parenteral, nebulizer or spacer? Eur Respir J. 1989; 2: 377-382. PubMed (Pubitemid 19146045)
19. Ballester E, Reyes A, Roca J, Guitart R, Wagner PD, Rodriguez-Roisin R. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax. 1989; 44: 258-267. doi:10.1136/thx.44.4.258 PubMed (Pubitemid 19113526)
20. Palmer KNV, Diament ML. Effect of salbutamol on spirometry and blood-gas tensions in bronchial asthma. BMJ. 1969; 1: 31-32. doi:10.1136/bmj.1.5635.31 PubMed
21. Taguchi O, Hida W, Nagami H, Inoue H, Takishima T. Possible site of bronchodilation due to inhaled procaterol aerosol in asthmatic patients. Eur J Clin Pharmacol. 1988; 34: 433-437. doi:10.1007/BF01046698 PubMed
22. Fontana GA, Lavorini F, Chiostri M, Castellani W, Boddi V, Pistolesi M. Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients. J Aerosol Med. 1999; 12: 177-185. doi:10.1089/jam.1999.12.177 PubMed (Pubitemid 29441628)
23. Chapman TT. Bronchodilator aerosols. BMJ. 1969; 4: 557. doi:10.1136/bmj.4.5682.557 PubMed
24. Himori N, Taira N. Assessment of the selectivity of OPC-2009, a new β2-adrenoceptor stimulant, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog. Br J Pharmacol. 1977; 61: 9-17. PubMed (Pubitemid 8171045)